BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
0.8711
-0.0230 (-2.57%)
Apr 25, 2025, 12:21 PM EDT - Market open
BIVI's stock price has decreased by -82.76% in the past year and price targets may not have had time to catch up.
BioVie Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+3,343.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| ThinkEquity | ThinkEquity | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +3,343.92% | Jul 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $120 → $50 | Buy | Maintains | $120 → $50 | +5,639.87% | Nov 30, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $110 | Buy | Reiterates | $110 | +12,527.71% | Aug 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $110 | Buy | Reiterates | $110 | +12,527.71% | Jul 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $110 | Buy | Reiterates | $110 | +12,527.71% | May 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $120 | Buy | Reiterates | $120 | +13,675.69% | May 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $120 | Buy | Reiterates | $120 | +13,675.69% | Feb 14, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $140 → $80 | Strong Buy | Maintains | $140 → $80 | +9,083.79% | Sep 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $70 | Buy | Initiates | $70 | +7,935.82% | Jul 22, 2022 |
| EF Hutton | EF Hutton | Strong Buy Maintains $90 → $140 | Strong Buy | Maintains | $90 → $140 | +15,971.63% | Mar 17, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $90 | Buy | Initiates | $90 | +10,231.76% | Mar 15, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $500 → $270 | Strong Buy | Maintains | $500 → $270 | +30,895.29% | Nov 30, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $470 | Strong Buy | Initiates | $470 | +53,854.77% | Jan 15, 2021 |